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TEAMING UP on AUTISM
AUTISM SPECTRUM DISORDER (ASD)—THE MOST COMMON
neurodevelopment disorder of childhood—
is characterized by challenges with social skills
and communication, repetitive behaviors and
sensory sensitivities.
The Jefferson Autism Research Program is
comprised of a team investigating the molecular,
genetic, synaptic and functional aspects of ASD.
Program researchers and clinicians translate newly
gained knowledge into treatments and behavioral
interventions intended to improve the function and
quality of life of those with ASD.
Roseann Schaaf, PhD, professor of occupational
therapy, leads a multi-project study investigating
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ASD-associated sensory perception and integration
difficulties. These often include hypersensitivity to
sounds, sights and tactile sensations and trouble
perceiving and integrating those sensory inputs—
and can lead individuals with ASD to become
overwhelmed and unresponsive. In addition, she
is investigating whether occupational therapy
designed to address ASD-related sensory challenges
can create long-lasting improvements in everyday
functional skills. Dr. Schaaf’s lab is conducting a
large, NIH-funded clinical trial of sensory integration
interventions in collaboration with Albert Einstein
Medical Center in New York. The project tracks both
improvements in children’s functional capacities
and changes in their brains’ neurological processing.
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And she is developing and testing an assessment
of sensory features in ASD, which should allow for
more precise identification and treatment of an
individual’s sensory challenges.
ASD is more prevalent in males, but the reason is not
clear. Diane Merry, PhD, professor of biochemistry
and molecular biology, is working toward an answer
by studying the basic biology of two proteins
produced by sex-chromosome-linked genes. These
proteins, which are critical to synapse formation
and stabilization, have increased expression in boys
with some types of ASD. For these studies, Dr. Merry
is creating specialized lines of patient-derived stem
cells, which can be turned into neurons in order to
study the biochemical and functional characteristics
of these synaptic proteins.
Mounting evidence indicates that ASD is a
“synaptopathy”—a disease rooted in atypical
function of the synapses through which brain
neurons communicate. Matthew Dalva, PhD,
professor of neuroscience, directs the Jefferson
Synaptic Biology Center (SBC), which seeks to
address how these building blocks of the brain
form, function and are linked to disease. His
laboratory uses leading-edge imaging and new
molecular tools to study how synapses are made
and lost, and what impact abnormal morphology
and quantity of synapses have on brain function.
Dr. Dalva’s current studies address synaptic
defects in ASD, but his work—and that of his SBC
colleagues—will likely also shed light on a range of
other neurological conditions including addiction,
Alzheimer’s and neurodegenerative disease.
Judith Ross, MD, professor of pediatrics, directs
the Extraordinary Kids Clinic at Nemours/Alfred
I. duPont Hospital for Children, which serves
children with X and Y chromosome variations.
She has more than 25 years of NIH-funded
pediatric research experience focused on
neurodevelopmental outcomes in children with
X and Y chromosomal disorders such as XYY,
Klinefelter and Turner syndromes. Her Jefferson
lab applies that basic science expertise and her
deep clinical experience to the challenge of
uncovering ASD’s genetic roots. 
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